[
 {
  "title": "Alzheimer’s Disease Prevention",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Richard discusses the various genetic and lifestyle factors that influence the risk of Alzheimer’s disease (AD). He explains how he diagnoses patients and personalizes care. They go through a protocol of preventative measures that have already produced marked results, and end with the uplifting message that one’s genetic predisposition does not seal one’s fate.",
  "content_length": 363,
  "content_tokens": 72,
  "embedding": []
 },
 {
  "title": "Influence of Genetics, Epigenetics, and Lifestyle on Alzheimer’s Disease Risk",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "The influence of genetics, epigenetics, and lifestyle on Alzheimer’s disease risk. The various manifestations of Alzheimer’s disease depending on the location of pathology. The three stages of Alzheimer’s disease.",
  "content_length": 213,
  "content_tokens": 44,
  "embedding": []
 },
 {
  "title": "Exercise and Alzheimer’s Disease Risk",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "How exercise reduces Alzheimer’s disease risk, and the different risk between males and females.",
  "content_length": 96,
  "content_tokens": 19,
  "embedding": []
 },
 {
  "title": "Importance of Knowing Your APOE Status",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Why knowing your APOE status is important, and whether certain people should be wearier of head trauma.",
  "content_length": 103,
  "content_tokens": 21,
  "embedding": []
 },
 {
  "title": "Personalized Care through Genetic Testing",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "How Richard uses genetic testing to personalize care.",
  "content_length": 53,
  "content_tokens": 10,
  "embedding": []
 },
 {
  "title": "Lifestyle Interventions for Alzheimer’s Prevention",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "The “ABCs” of Alzheimer’s prevention, lifestyle interventions, and a personal protocol for reducing risk.",
  "content_length": 105,
  "content_tokens": 25,
  "embedding": []
 },
 {
  "title": "Treatment for People with the ApoE4 Variant",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Unique treatment for people with the ApoE4 variant.",
  "content_length": 51,
  "content_tokens": 12,
  "embedding": []
 },
 {
  "title": "Opinion on CBD and THC for Disease Prevention",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Richard’s mixed opinion on CBD and THC as a tool for disease prevention.",
  "content_length": 72,
  "content_tokens": 17,
  "embedding": []
 },
 {
  "title": "Cognitive Testing Procedures",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Cognitive testing procedures, and how these tests furthered commitment to disease prevention protocol.",
  "content_length": 102,
  "content_tokens": 17,
  "embedding": []
 },
 {
  "title": "Relevance of Sense of Smell and Hearing in Alzheimer’s Disease Risk and Prevention",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "The relevance of sense of smell and hearing in Alzheimer’s disease risk and prevention.",
  "content_length": 87,
  "content_tokens": 18,
  "embedding": []
 },
 {
  "title": "Emotional Benefit of Knowing You Have Control Over Your Health",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "The emotional benefit of knowing you have control over your mental and physical health.",
  "content_length": 87,
  "content_tokens": 15,
  "embedding": []
 },
 {
  "title": "Insights on Alzheimer’s disease, cancer, exercise, nutrition, and fasting",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Rhonda provides her latest thinking as it relates to Alzheimer's disease including the possibility of a vascular hypothesis as well as the factors that can impact disease risk such as type 2 diabetes, blood pressure, omega supplementation, exercise, sauna, and more. She also touches on cancer risk including the relationship between cancer and exercise as well as the link between alcohol consumption and cancer. Additionally, Rhonda explains her new focus on exercise and protein consumption as well as how her perspective has shifted as it pertains to fasting and time-restricted feeding.",
  "content_length": 591,
  "content_tokens": 107,
  "embedding": []
 },
 {
  "title": "Optimizing brain health: Alzheimer's disease risk factors, APOE, prevention strategies",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "The breakdown of the blood-brain barrier in neurodegenerative disease. An explanation for the observation that type 2 diabetes increases risk of Alzheimer’s disease. The role of omega-3 fatty acids (EPA and DHA) in brain health and prevention of neurodegeneration. Blood pressure: an important modifiable lifestyle factor that can affect Alzheimer's disease risk. Possible mechanisms by which exercise reduces the risk of Alzheimer’s disease. The relationship between cardiorespiratory fitness and dementia risk. How exercise may reduce the risk of cancer. Impact of alcohol consumption on breast cancer risk and overall health. Exercise as an intervention for poor sleep habits. The longevity benefits of consuming adequate protein and strength training to preserve muscle mass and strength.",
  "content_length": 792,
  "content_tokens": 150,
  "embedding": []
 },
 {
  "title": "Preventing cardiovascular disease: the latest in diagnostic imaging, blood pressure, metabolic health",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "",
  "content_length": 0,
  "content_tokens": 0,
  "embedding": []
 },
 {
  "title": "Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "",
  "content_length": 0,
  "content_tokens": 0,
  "embedding": []
 },
 {
  "title": "The influence of genetics, epigenetics, and lifestyle on Alzheimer’s disease risk",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Alzheimer’s begins in the brain about a decade before the first symptoms of memory loss. Onset of Alzheimer’s symptoms usually occurs in one’s seventies, but with early-onset Alzheimer’s disease, symptoms can begin in one’s forties or fifties. While genetics is often responsible for an early onset of Alzheimer’s disease, there are cases when there is more to the story that can cause an earlier onset (lifestyle, head trauma, comorbidities, etc.).",
  "content_length": 449,
  "content_tokens": 112,
  "embedding": []
 },
 {
  "title": "Potential Causes of Early Onset Alzheimer's",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Lifestyle, exposure to certain elements, head trauma, uncontrolled diabetes, high blood pressure, and cholesterol are all factors that could potentially cause a late onset Alzheimer's case to start earlier. Genetic risk factors also play a role, with variations in the genes for presenilin-1, presenilin-2, and amyloid precursor protein gene mutation known to cause early-onset Alzheimer's disease. However, these variations are quite rare.",
  "content_length": 440,
  "content_tokens": 92,
  "embedding": []
 },
 {
  "title": "Genetic and Epigenetic Causes of Alzheimer's",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Most people that get Alzheimer's disease earlier in life don't have 'early-onset Alzheimer's disease' but rather they have a 'milieu of things' aka polygenic risk and epigenetics that simply push the onset of Alzheimer's earlier in life. For example, the apolipoprotein E (ApoE) gene variants. The E4 variant raises Alzheimer's disease risk, while the E2 variant is protective and the E3 variant, which is most common, is neutral.",
  "content_length": 430,
  "content_tokens": 100,
  "embedding": []
 },
 {
  "title": "Lifestyle and Behavioral Characteristics Influencing Alzheimer's",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Diet, exercise, head trauma, and comorbidities such as diabetes, high blood pressure, and cholesterol can influence the onset and progression of Alzheimer's disease.",
  "content_length": 165,
  "content_tokens": 34,
  "embedding": []
 },
 {
  "title": "Future of Alzheimer's Disease Prevention and Treatment",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "The future of Alzheimer's prevention will be based on precision medicine. This involves understanding all the individual genes that impact a person's risk, figuring out what they are, figuring out what their biological function is, figuring out why it puts a person down the path towards Alzheimer's and then telling that person to do specific things to get them off the path towards Alzheimer's.",
  "content_length": 396,
  "content_tokens": 73,
  "embedding": []
 },
 {
  "title": "Apolipoprotein E (ApoE) and Alzheimer's Risk",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "ApoE is involved in cholesterol transport. The ApoE4 variant is also a cardiovascular risk factor. People with the ApoE4 variant typically accumulate more amyloid protein in their brains.",
  "content_length": 187,
  "content_tokens": 41,
  "embedding": []
 },
 {
  "title": "Stages of Alzheimer's Disease",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "The three stages of Alzheimer's disease are: Stage 1: Preclinical phase where Alzheimer's disease has started in the brain, but there are no clinically apparent symptoms. Stage 2: Mild cognitive impairment (MCI) due to Alzheimer's. There are enough memory glitches and other changes to where it's noticeable, but the person can still take care of themselves. Stage 3: Dementia.",
  "content_length": 377,
  "content_tokens": 79,
  "embedding": []
 },
 {
  "title": "Exercise and Alzheimer's Disease Risk",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Exercise, particularly high-intensity interval training, is considered a key factor in Alzheimer's prevention. Physical activity can significantly influence cognitive function, especially in people with the APOE4 variant.",
  "content_length": 221,
  "content_tokens": 38,
  "embedding": []
 },
 {
  "title": "Gender Differences in Alzheimer's Risk",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "The risk of Alzheimer's is more pronounced in women, possibly related to menopause. During perimenopause, there are metabolic shifts in the brain that can predispose to acceleration of Alzheimer's pathology. Other factors contributing to risk in women include widowhood and abdominal obesity.",
  "content_length": 292,
  "content_tokens": 56,
  "embedding": []
 },
 {
  "title": "Muscle Mass and Body Fat in Men",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "In men, muscle mass is a more important predictor than body fat, but we do not yet know why.",
  "content_length": 92,
  "content_tokens": 22,
  "embedding": []
 },
 {
  "title": "Importance of Knowing APOE Status",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Knowing your APOE status is important, and certain people should be wearier of head trauma. People with E4/E4 don’t absorb omega-3 fats from eating fatty fish very well, therefore they should be supplementing with omega-3 from an early age to protect the brain. The REVEAL study showed that disclosing ApoE4 status did not cause clinically significant anxiety or depression.",
  "content_length": 374,
  "content_tokens": 83,
  "embedding": []
 },
 {
  "title": "Genetic Testing for Personalized Care",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Genetic testing is used to personalize care. There are about 30 genes that are known to influence Alzheimer’s risk. Alzheimer’s is a medical condition influenced by various factors such as lipid path, inflammation path, potentially infectious path, or the head trauma path. Other genes that are looked at include vascular genes like FTO and other genes related to lipid metabolism like PCSK9, longevity genes such as those related to FOXOs and Klotho, and the gene for TNF-α, an inflammatory cytokine.",
  "content_length": 501,
  "content_tokens": 108,
  "embedding": []
 },
 {
  "title": "Alzheimer’s Prevention and Lifestyle Interventions",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Alzheimer’s prevention involves lifestyle interventions. High risk patients are those with notable family history, at least one copy of the ApoE4 gene, or those over 60. Richard’s “ABCs” of Alzheimer’s prevention include anthropometrics, mainly body composition, blood biomarkers, primarily related to cholesterol, inflammation, metabolism, nutrition, and genetics, and cognitive function. Exercise, Omega-3 fats, lowering inflammation, lowering homocysteine, and optimizing Vitamin D are part of the protocol.",
  "content_length": 510,
  "content_tokens": 111,
  "embedding": []
 },
 {
  "title": "Unique Treatment for People with the ApoE4 Variant",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "ApoE4 influences risk and prevention. Being an ApoE4 carrier exacerbates the negative effects of being sedentary. Tobacco use has more of a negative effect in ApoE4 carriers. Cognitive engagement may be more important for ApoE4 carriers. As already mentioned, ApoE4 carriers need higher doses of omega-3 fatty acids.",
  "content_length": 316,
  "content_tokens": 73,
  "embedding": []
 },
 {
  "title": "CBD and THC for Disease Prevention",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "A precision medicine approach applies to CBD and THC. The benefit is dependent on the ratio of CBD to THC. Consuming it in edible form makes more sense than smoking it. Evidence in regard to helping versus accelerating Alzheimer’s pathology is mixed.",
  "content_length": 250,
  "content_tokens": 50,
  "embedding": []
 },
 {
  "title": "Cognitive Testing Procedures",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Cognitive testing is used in Richard’s clinic. The testing is sensitive enough to detect changes in brain function before symptoms occur. Testing is not perfect because people have good days and bad days. But Richard says he can look for specific things that can indicate a confounder.",
  "content_length": 285,
  "content_tokens": 57,
  "embedding": []
 },
 {
  "title": "Sense of Smell and Hearing in Alzheimer’s Disease Risk and Prevention",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Loss of smell and inability to identify certain smells were originally viewed as warning signs for Parkinson’s disease, but as Richard puts it, this can and also be “a harbinger of Alzheimer’s disease”. Richard uses smell sensitivity as part of his testing battery.",
  "content_length": 265,
  "content_tokens": 59,
  "embedding": []
 },
 {
  "title": "Hearing Loss and Alzheimer's Disease",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Hearing loss was identified as one of the strongest modifiable risk factors for dementia in the 2020 report of the Lancet Commission. The reason why is not clearly known, but it may be related to disengaging. Screening for hearing, perhaps at a certain age, should be included in medical evaluations.",
  "content_length": 300,
  "content_tokens": 60,
  "embedding": []
 },
 {
  "title": "Emotional Benefit of Health Control",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Having control over mental and physical health can have emotional benefits. Seeing improvements in health metrics can provide hope and positively impact physical and cognitive health. There is a belief that genetics don't seal your fate and that control over health can reduce fear and depression associated with potential health issues.",
  "content_length": 337,
  "content_tokens": 55,
  "embedding": []
 },
 {
  "title": "Hilarity for Charity (HFC) and Alzheimer's Disease",
  "date": "November 23, 2020",
  "context": "Cognitive Health & Neurodegenerative Disease",
  "people": "Peter Attia",
  "content": "Hilarity for Charity (HFC) is a charitable organization focused on Alzheimer's disease. It aims to help people and their caregivers who need help now, and to help people minimize future risk. HFC sends caregivers to people’s homes to give the primary caregiver a break and trains these caregivers. HFC also encourages young people to share their stories and start taking care of their brains. HFC funds research, but to date they have not raised enough money to fund major studies.",
  "content_length": 481,
  "content_tokens": 100,
  "embedding": []
 }
]